_version_ 1783711212960219136
author Zhu, Na
Swietlik, Emilia M.
Welch, Carrie L.
Pauciulo, Michael W.
Hagen, Jacob J.
Zhou, Xueya
Guo, Yicheng
Karten, Johannes
Pandya, Divya
Tilly, Tobias
Lutz, Katie A.
Martin, Jennifer M.
Treacy, Carmen M.
Rosenzweig, Erika B.
Krishnan, Usha
Coleman, Anna W.
Gonzaga-Jauregui, Claudia
Lawrie, Allan
Trembath, Richard C.
Wilkins, Martin R.
Morrell, Nicholas W.
Shen, Yufeng
Gräf, Stefan
Nichols, William C.
Chung, Wendy K.
author_facet Zhu, Na
Swietlik, Emilia M.
Welch, Carrie L.
Pauciulo, Michael W.
Hagen, Jacob J.
Zhou, Xueya
Guo, Yicheng
Karten, Johannes
Pandya, Divya
Tilly, Tobias
Lutz, Katie A.
Martin, Jennifer M.
Treacy, Carmen M.
Rosenzweig, Erika B.
Krishnan, Usha
Coleman, Anna W.
Gonzaga-Jauregui, Claudia
Lawrie, Allan
Trembath, Richard C.
Wilkins, Martin R.
Morrell, Nicholas W.
Shen, Yufeng
Gräf, Stefan
Nichols, William C.
Chung, Wendy K.
author_sort Zhu, Na
collection PubMed
description
format Online
Article
Text
id pubmed-8220777
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82207772021-06-24 Correction to: Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH Zhu, Na Swietlik, Emilia M. Welch, Carrie L. Pauciulo, Michael W. Hagen, Jacob J. Zhou, Xueya Guo, Yicheng Karten, Johannes Pandya, Divya Tilly, Tobias Lutz, Katie A. Martin, Jennifer M. Treacy, Carmen M. Rosenzweig, Erika B. Krishnan, Usha Coleman, Anna W. Gonzaga-Jauregui, Claudia Lawrie, Allan Trembath, Richard C. Wilkins, Martin R. Morrell, Nicholas W. Shen, Yufeng Gräf, Stefan Nichols, William C. Chung, Wendy K. Genome Med Correction BioMed Central 2021-06-22 /pmc/articles/PMC8220777/ /pubmed/34158098 http://dx.doi.org/10.1186/s13073-021-00915-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Zhu, Na
Swietlik, Emilia M.
Welch, Carrie L.
Pauciulo, Michael W.
Hagen, Jacob J.
Zhou, Xueya
Guo, Yicheng
Karten, Johannes
Pandya, Divya
Tilly, Tobias
Lutz, Katie A.
Martin, Jennifer M.
Treacy, Carmen M.
Rosenzweig, Erika B.
Krishnan, Usha
Coleman, Anna W.
Gonzaga-Jauregui, Claudia
Lawrie, Allan
Trembath, Richard C.
Wilkins, Martin R.
Morrell, Nicholas W.
Shen, Yufeng
Gräf, Stefan
Nichols, William C.
Chung, Wendy K.
Correction to: Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH
title Correction to: Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH
title_full Correction to: Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH
title_fullStr Correction to: Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH
title_full_unstemmed Correction to: Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH
title_short Correction to: Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH
title_sort correction to: rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates fbln2, pdgfd, and rare de novo variants in pah
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220777/
https://www.ncbi.nlm.nih.gov/pubmed/34158098
http://dx.doi.org/10.1186/s13073-021-00915-w
work_keys_str_mv AT zhuna correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT swietlikemiliam correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT welchcarriel correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT pauciulomichaelw correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT hagenjacobj correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT zhouxueya correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT guoyicheng correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT kartenjohannes correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT pandyadivya correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT tillytobias correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT lutzkatiea correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT martinjenniferm correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT treacycarmenm correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT rosenzweigerikab correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT krishnanusha correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT colemanannaw correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT gonzagajaureguiclaudia correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT lawrieallan correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT trembathrichardc correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT wilkinsmartinr correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT morrellnicholasw correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT shenyufeng correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT grafstefan correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT nicholswilliamc correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah
AT chungwendyk correctiontorarevariantanalysisof4241pulmonaryarterialhypertensioncasesfromaninternationalconsortiumimplicatesfbln2pdgfdandraredenovovariantsinpah